Hershey set to announce CEO Michele Buck to step down, Semafor reports-February 2024-www.financetom.com

Hershey set to announce CEO Michele Buck to step down, Semafor reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Hershey set to announce CEO Michele Buck to step down, Semafor reports

Jan 10, 2025 12:38 PM

Jan 10 (Reuters) - Chocolate maker Hershey is

set to announce the departure of CEO Michele Buck, Semafor

reported on Friday, citing people familiar with the matter.

Previous page： What's Going On With Sonoma Pharmaceuticals Stock Tuesday? Next page： Ex-Barclays CEO Staley insists he was 'shocked' by Epstein's arrest

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

What's Going On With Sonoma Pharmaceuticals Stock Tuesday?

Mar 11, 2025

Sonoma Pharmaceuticals, Inc. ( SNOA ) stock is trading higher on Tuesday after the company announced that it secured U.K. regulatory clearance for its key wound care and dermatology products. The Details: Sonoma received clearance from the Medicines & Healthcare products Regulatory Agency for five products, including its hypochlorous acid-based wound irrigation solution, scar management products, wound hydrogel and skin...

Ex-Barclays CEO Staley insists he was 'shocked' by Epstein's arrest

Mar 11, 2025

* Ex-Barclays ( JJCTF ) boss says he had no knowledge of Epstein's crimes * Staley facing finance industry ban, $2.3 million fine * FCA says Staley approved misleading letter about relationship (Recasts with later evidence, adds details in paragraphs 4-8, 14-17) By Sam Tobin LONDON, March 11 (Reuters) - Ex-Barclays boss Jes Staley on Tuesday insisted he was shocked...

--Boeing Delivers 44 Aircraft in February Compared With 45 in January

Mar 11, 2025

11:16 AM EDT, 03/11/2025 (MT Newswires) -- Price: 147.42, Change: -0.74, Percent Change: -0.50 ...

Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million

Mar 11, 2025

On Tuesday, Bioventus Inc ( BVS ). reported fourth-quarter adjusted EPS of 15 cents, up from 7 cents, beating the consensus of 8 cents. The medical device company reported sales of $153.6 million, up 13.5% year over year, beating the consensus of $145.2 million, driven by double-digit growth in pain treatments and surgical solutions. Pain treatment sales increased 18.7% to...